March 26, 2025

What’s Brewing at Work May Raise Heart Risks

Research identifies high levels of LDL-raising compounds in workplace coffee machine brews, potentially increasing cardiovascular risk for regular consumers.

Conexiant

March 25, 2025

Most Pediatric Valve Implants Used Off-Label

Fewer than 10% of cardiac valve devices implanted in U.S. pediatric patients were FDA approved for children.

Conexiant

March 24, 2025

Cannabis Use: Multicenter Study Links to Increased MI, Stroke Risks

Cannabis use associated with over sixfold higher risk of myocardial infarction in otherwise healthy adults, according to new multicenter study.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 19, 2025

Study Shows Widespread Delays in Medical Device Reporting to FDA

Late reporting was concentrated among a small number of manufacturers, with 3 manufacturers and 13 devices accounting for 54.8% of all late reports between 2019 and 2022.

Conexiant

March 18, 2025

Study Backs Earlier CABG Timing After Ticagrelor Cessation

A randomized trial found that CABG surgery performed 2 to 3 days after ticagrelor cessation resulted in no increase in severe bleeding compared to the standard 5- to 7-day delay.

Conexiant

March 18, 2025

Medtronic Recall: FDA Issues Highest-Risk Warning

The FDA has classified the recall of Medtronic’s Pipeline Vantage embolization devices as its most serious, citing risks of thrombosis, stroke, and death. The devices, used to treat brain aneurysms, have been linked to multiple patient injuries and fatalities.

Reuters

March 14, 2025

Maternal Health Trajectories: CVD Risks Start Before Pregnancy

Women with adverse pregnancy outcomes had higher BMI, BP, and glucose 10 years before pregnancy and persistently elevated risks up to 15 years postpartum, a new cohort study finds.

Conexiant

March 14, 2025

Reduced-Dose Anticoagulants Lower Bleeding, Study Finds

Findings indicate that while non-inferiority was not established, the reduced-dose regimen resulted in fewer bleeding complications without a marked increase in venous thromboembolism (VTE) recurrence.

Conexiant